top of page

China Liberal Education Holdings Limited Announces Commencement of Trading on the Nasdaq Capital Market Under Ticker Symbol “CLEU”


BEIJING, CHINA, and New York, May 8, 2020 –- Boustead Securities client China Liberal Education Holdings Limited (“China Liberal”), an educational services provider, today announced that its ordinary shares have commenced trading on The Nasdaq Capital Market under the ticker symbol “CLEU”.

China Liberal priced its initial public offering (“IPO”) of 1,333,333 ordinary shares at $6.00 per share, before underwriting discounts and offering expenses, resulting in gross proceeds of $8,000,000. The offering was conducted on a firm commitment basis and expected to close on May 12, 2020, subject to customary closing conditions.

Boustead Securities, LLC (“Boustead”), acted as the sole underwriter for the offering, with Zinvest Global Limited in Hong Kong serving as Asian book runner. Hunter Taubman Fischer & Li LLC acted as legal counsel to China Liberal, and Pryor Cashman LLP acted as legal counsel to Boustead.

China Liberal has granted Boustead a 45-day option to purchase up to an additional 200,000 ordinary shares at the IPO price, less underwriting discounts and commissions, to cover over-allotments, if any.

A registration statement on Form F-1 (File No. 333-233016), including a prospectus relating to the offering, was filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective by the SEC. The offering of the ordinary shares was made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained on the SEC’s website (www.sec.gov) and may also be obtained from Boustead Securities, LLC, by email at offerings@boustead1828.com or telephone +1 (949) 502-4409 or standard mail to Boustead Securities, LLC, Attn: Equity Capital Markets, 6 Venture, Suite 395, Irvine, CA 92618, USA.

Before you invest, you should read the prospectus and other documents China Liberal has filed or will file with the SEC for more complete information about China Liberal and the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. There is no guarantee that any specific outcome would be achieved. Securities may be illiquid, speculative and there is a risk of total loss. Past performance is not indicative of future results.

About China Liberal Education Holdings Limited

China Liberal, headquartered in Beijing, is an educational services provider in China. It provides a wide range of services, including those under Sino-foreign jointly managed academic programs; overseas study consulting services; technological consulting services for Chinese universities to improve their campus information and data management system and to optimize their teaching, operating and management environment, creating a “smart campus”; and tailored job readiness training to graduating students.

About Boustead Securities, LLC

Boustead Securities, LLC (“Boustead”) is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. For more information, visit www.boustead1828.com.

CONTACT

Boustead Securities, LLC

Dan McClory, Head of Equity Capital Markets and Head of China

+1 949 502 4409

Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

G Medical Innovations engages Boustead Securities and Fosun Hani Securities Limited as Joint Financial and Listing Advisors for NASDAQ IPO

Mobile and e-Health company G Medical Innovations (ASX: GMV) (“G Medical” or the “Company”) announced that it has engaged Boustead Securities, LLC (“Boustead”) and Fosun Hani Securities Limited (“Fosun Hani”) as Joint Financial and Listing Advisors to the Company’s planned initial public offering (“IPO”) on the NASDAQ Stock Exchange (“NASDAQ”).

The engagement contemplates that Boustead and Fosun Hani will be acting as co-underwriters, subject to the completion of an effective registration statement, Nasdaq approval, and the execution of a formal underwriting agreement for the Company’s planned IPO in Q3 of 2020.

While the Company advises there is no certainty that a Nasdaq listing will proceed, both Boustead and Fosun Hani will be instrumental as G Medical continues to explore a Nasdaq listing.

CEO and Executive Director Dr Yacov Geva said: “Engaging Boustead and Fosun Hani is an important step to progress the Company’s potential IPO on the NASDAQ. Both parties are incredibly experienced, have strong relationships with investors globally and will assist the Company in its’ objective of enhancing value for its shareholder base.”

Boustead Securities Head of Equity Capital Markets Dan McClory stated: “With the successful rollout of G Medical’s Prizma monitor, a device that connects your health to your smartphone, we are looking forward to bringing a fast-growing, unique company to investors that previously have had limited access to such opportunities.”

About G Medical Innovations

G Medical (ASX: GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company leverages the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity.

The Company specialises in innovative next generation mobile and e-health solutions using its suite of proprietary devices and software solutions, as well as patient service operations, with a view to driving multiple and recurring revenue streams, across numerous verticals and territories.

About G Medical products G Medical offers a suite of consumer and professional clinical-grade products (with regulatory approval) that are positioned to streamline healthcare services, improve remote access to medical data, reduce costs, improve quality of care, and make healthcare more personalized and precise. Currently the Company is focusing on two main verticals. The ‘Prizma’ Medical Smartphone Case is one of two key products developed by G Medical and is aimed at everyday consumers focused on their medical health and wellbeing. The ‘Prizma’ allows consumers to turn their smartphone into a mobile medical monitor to measure a wide range of vital signs, with the added advantage that users are able to store their medical data in the cloud and share it with third parties such as healthcare professionals and family members.

G Medical also offers a professional real-time patient continuous monitoring solution, G Medical’s Vital Signs Monitoring System (VSMS) and G Medical Patch (GMP). This modular solution measures a wide range of vital signs that are automatically presented in a call centre (IDTF) or a hospital setting. The GMP assists in diagnosing patient complaints and conditions remotely, from pre-hospitalisation, hospitalisation and through to post discharge home-based settings. For more information on G Medical, please visit www.gmedinnovations.com

About Boustead Securities, LLC Boustead Securities, LLC (“Boustead”) is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information, please visit www.boustead1828.com. About Fosun Hani Securities Limited Fosun Hani Securities Limited is a wholly-owned subsidiary of Fosun International Limited (HKEx: 00656), a leading global investment group (Fosun Group). Fosun Hani Securities Limited is Fosun Group's integrated financial hub and primary investment arm in Hong Kong. Established in 1987, Fosun Hani Securities Limited is a participant member of The Stock Exchange of Hong Kong Limited. For more information, please visit https://www.fosun.com/language/en/p/6613.html. This press release is not a solicitation or offer to buy or sell securities. Investments may be speculative, illiquid and carry a risk of loss. Past performance is not indicative of future results. There is no guarantee that any specific outcome will be achieved. Clinical trials are in early stages. Forward-Looking Statements This announcement contains forward-looking statements. Forward-looking statements provide our current expectations or forecasts of future events. Forward-looking statements include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “will” or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Examples of forward-looking statements in this announcement include, but are not limited to, statements regarding our disclosure concerning the Company’s operations, cash flows, financial position and dividend policy.

bottom of page